Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014

Fleming S, Yannakou CK, Haeusler GM, Clark J, Grigg A, Heath CH, Bajel A, van Hal SJ, Chen SC, Milliken ST, Morrissey CO, Tam CS, Szer J, Weinkove R, Slavin MA

(2014), Intern Med J, 44(12b), 1283-97

Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction

Wong G, Trevillyan JM, Fatou B, Cinel M, Weir JM, Hoy JF, Meikle PJ

(2014), PLoS One, 9(4), e94810

Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand

van Hal SJ, Gilroy NM, Morrissey CO, Worth LJ, Szer J, Tam CS, Chen SC, Thursky KA, Slavin MA

(2014), Intern Med J, 44(12b), 1277-82

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Rasmussen TA, Tolstrup M, Brinkmann C, Olesen R, Erikstrup C, Solomon A, Winkelmann A, Palmer SE, Dinarello CA, Buzon MJ, Lichterfield M, Lewin SR, Østergaard LJ, SØgaard OS

(2014), Lancet HIV, 1(1), e13-21

Determinants of suicide and accidental or violent death in the Australian HIV Observational Database

McManus H, Petoumenos K, Franic T, Kelly MD, Watson J, O'Connor CC, Jeanes M, Hoy J, Cooper DA, Law MG; Australian HIV Observational Database

(2014), PLoS One, 9(2), e89089

Medical graduates' knowledge of bloodborne viruses and occupational exposures

Koehler N, Vujovic O, Dendle C, McMenamin C

(2014), Am J Infect Control, 42(2), 203-5

The significance of HIV 'blips' in resource-limited settings: is it the same? analysis of the treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD)

Kanapathipillai R, McManus H, Kamarulzaman A, Lim PL, Templeton DJ, Law M, Woolley I.

(2014), PLoS One, 9(2), e86122

Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ritonavir compared with standard second-line therapy

Haskelberg H, Mallon PW, Hoy J, Amin J, Moore C, Phanuphak P, Ferret S, Belloso WH, Boyd MA, Cooper DA, Emery S

(2014), J Acquir Immune Defic Syndr, 67(2), 161-8

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel

Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA; International Antiviral Society-USA Panel

(2014), JAMA, 312(4), 410-25

Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: results from the Strategies for Management of Antiretroviral Therapy [SMART] Study

Dawood FZ, Roediger MP, Grandits G, Miller D, Fisher M, Zhang ZM, Hodder S, Hoy JF, Lundgren JD, Neaton JD, Soliman EZ; INSIGHT SMART Study Group

(2014), J Electrocardiol, 47(2), 264-71

Switch from tenofovir to raltegravir increases low bone mineral density and decreases markers of bone turnover over 48 weeks

Bloch M, Tong WW, Hoy J, Baker D, Lee FJ, Richardson R, Carr A; TROP (Switch from Tenofovir to Raltegravir for Low Bone Density) study team

(2014), HIV Med, 15(6), 373-80

CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals

Bastidas S, Graw F, Smith MZ, Kuster H, Günthard HF, Oxenius A

(2014), J Immunol, 192(4), 1732-44

What has the Young Physician Leaders Programme achieved?

Giles ML, Vincent FB, Volkenstein S, Shefin SM, Silva A, Fredrick F; Young Physician Leadership Group 2013

(2014), Lancet, 384(9937), 26-7

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

Seymour JF, Pfreundschuh M, Trnĕný M, Sehn LH, Catalano J, Csinady E, Moore N, Coiffier B; MAIN Study Investigators

(2014), Haematologica, 99(8), 1343-9

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Mesa RA, Kiladjian JJ, Verstovsek S, Al-Ali HK, Gotlib J, Gisslinger H, Levy R, Siulnik A, Gupta V, Khan M, DiPersio JF, McQuitty M, Catalano JV, Hunter DS, Knoops L, Deininger M, Cervantes F, Miller C, Vannucchi AM, Silver RT, Barbui T, Talpaz M, Barosi

(2014), Haematologica, 99(2), 292-8

Changing microbial epidemiology in hematopoietic stem cell transplant recipients: increasing resistance over a 9-year period

Macesic N, Morrissey CO, Cheng AC, Spencer A, Peleg AY

(2014), Transpl Infect Dis, 16(6), 887-96

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphoma

Cheah CY, Herbert KE, O'Rourke K, Kennedy GA, George A, Fedele PL, Gilbertson M, Tan SY, Ritchie DS, Opat SS, Prince HM, Dickinson M, Burbury K, Wolf M, Januszewicz EH, Tam CS, Westerman DA, Carney DA, Harrison SJ, Seymour JF

(2014), Br J Cancer, 111(6), 1072-9

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, Lee JJ, Chen C, Oriol A, de la Rubia J, Qiu L, White DJ, Binder D, Anderson K, Fermand JP

(2014), N Engl J Med, 371(10), 906-17

Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014

Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah M, May M, Heath CH, Grigg A, Bardy PG, Kwan J, Kirsa SW, Slavin M, Gottlieb T, Chen S

(2014), Intern Med J, 44(12b), 1298-314

The dual-specificity phosphatase 2 (DUSP2) does not regulate obesity-associated inflammation or insulin resistance in mice

Lancaster GI, Kraakman MJ, Kammoun HL, Langley KG, Estevez E, Banerjee A, Grumont RJ, Febbraio MA, Gerondakis S

(2014), PLoS One, 9(11), e111524

487 488 489 490 491